Insights from 2023 SABCS
Playback speed
10 seconds
SABCS 2023 Insights: "Final iDFS Analysis From the NATALEE Trial - Ribociclib + NSAI as Adjuvant Treatment in Patients With HR+/HER2- eBC"
By
Insights from 2023 SABCS
FEATURING
Gabriel Hortobagyi
By
Insights from 2023 SABCS
FEATURING
Gabriel Hortobagyi
486 views
December 15, 2023
Comments 0
Login to view comments.
Click here to Login
Videos